Lv5
808 积分 2023-11-23 加入
Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
1个月前
已完结
[Research Progress on the Influence of Blood Tumor Microen-vironment on the Efficacy and the Adverse Reactions of CAR-T Cell Immunotherapy--Review]
1个月前
已关闭
[Research Progress on the Influence of Blood Tumor Microen-vironment on the Efficacy and the Adverse Reactions of CAR-T Cell Immunotherapy--Review]
1个月前
已关闭
CAR T-cell-associated neurotoxicity: A comprehensive review
1个月前
已完结
From the IASLC Tobacco Control Committee
1个月前
已完结
Novel strategies to manage CAR-T cell toxicity
2个月前
已完结
BCMA-directed CAR T-cell Therapy in patients with multiple myeloma and CNS involvement
4个月前
已关闭
Central nervous system multiple myeloma: A real‐world multi‐institutional study of the Greek Myeloma Study Group
4个月前
已完结
Central nervous system multiple myeloma: A real‐world multi‐institutional study of the Greek Myeloma Study Group
4个月前
已完结
Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy
4个月前
已完结
皖公网安备34019202002308
